Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Online Appendix for the following JACC article TITLE: Correction of Mitral Regurgitation in Nonresponders to Cardiac Resynchronization Therapy by MitraClip Improves Symptoms and Promotes Reverse Remodeling AUTHORS: Angelo Auricchio, MD, PHD, Wolfgang Schillinger, MD, Sven Meyer, MD, Francesco Maisano, MD, Rainer Hoffmann, MD, Gian Paolo Ussia, MD, Giovanni B. Pedrazzini, MD, Jan van der Heyden, MD, Simona Fratini, MD, PHD, Catherine Klersy, MD, MSc, Jan Komtebedde, DVM, Olaf Franzen, MD, on behalf of the PERMIT-CARE Investigators ____________________________________________________________________________ APPENDIX PERMIT-CARE registry investigators Division of Cardiology, Fondazione Cardiocentro Ticino, Lugano, Switzerland: Angelo Auricchio, MD PhD, Giovanni B. Pedrazzini, MD; Elena Pasotti, MD; Francesco Faletra, MD; Simona Fratini, MD PhD; Francois Regoli, MD; Jan Komtebedde, DVM; Tiziano Moccetti, MD. University Medical Center Göttingen, Department of Cardiology and Pneumology, Göttingen, Germany: Wolfgang Schillinger, MD; Thomas Athansiou, MD; Rolf Wachter, MD; Ninja Weicken, MS; Lars Berg, MS. University Heart Center Hamburg, University Medical Center Hamburg-Eppendorf, Department of General and Interventional Cardiology: Sven Meyer, MD, Olaf Franzen, MD, Angelika CostardJäckle, MD; Stephan Baldus, MD; Thomas Meinertz, MD. Cardiac Surgery and Interventional Cardiology San Raffaele Hospital, Milan, Italy: Francesco Maisano, MD, Giovanni La Canna, MD, Ottavio Alfieri, MD, Antonio Colombo, MD, Andrea Giacomini, MD, Paolo Denti, MD, Cosmo Godino, MD, Nicola Buzzati, MD. Medical Clinic I, University RWTH Aachen, Aachen, Germany: Rainer Hoffmann, MD, Sebastian Reith, MD, Ralf Herpertz, Kathrin Brehmer, MD. Cardiology Department, Ferrarotto Hospital, University of Catania, Catania, Italy: Gian Paolo Ussia, MD, Corrado Tamburino, MD, PhD, Valeria Calvi, MD, PhD, Salvatore Scandura, MD Cardiology St. Antonius Ziekenhuis, Nieuwegein, Netherlands: Jan Van der Heyden, MD, Martin J Swaans, MD, Ben JL Van den Branden, MD, Marco C Post, MD, PhD, Benno JWM Rensing, MD, PhD, Frank D Eefting, MD, Herbert WM Plokker, MD, PhD, Wiebren Jaarsma MD,PhD. Association of clinical and echocardiographic characteristics with survival after MitraClip treatment. Survivors Non-survivors P (n=40) (n=9) Age (yy) 69.59 ± 9.40 71.44 ± 8.46 0.62 Male gender 35 (87.5%) 7 (77.8%) 0.58 Ischemic cardiomyopathy 30 (75%) 5 (56%) 0.36 Previous revascularization (%) 20 (50%) 2 (22.2%) 0.17 Previous valvular surgery (%) 2 (5%) 2 (22.2%) 0.04 QRS width (msec) 148.3 ± 27.70 159.2 ± 39.4 0.37 27 (67.5%) / 13 (32.5%) 5 (55.6%) / 4 (44.4%) 0.5 Previous stroke 4 (10%) 3 (33.3%) 0.07 Diabetes 9 (22.5%) 2 (22.2%) 0.88 COPD 12 (30%) 2 (22.2%) 0.73 Renal insufficiency 28 (70%) 6 (66.7%) 0.78 NT-pro-BNP (ng/L) 3567 (1726-6473) 10400 (8948-10900)* 0.06 Logistic Euroscore 26.84 ± 16.56 35.22 ± 23.42 0.09 STS score 12.83 ± 13.82 19.74 ± 19.01 0.09 Left ventricular end-diastolic volume (ml) 235.97 ± 74.48 254.88 ± 67.30 0.39 Left ventricular end-systolic volume (ml) 171.38 ± 62.45 191.88 ± 58.30 0.29 Left ventricular ejection fraction (%) 28.08 ± 8.74 23.33 ±8.25 0.12 Mitral regurgitation >2+ 40 (100%) 9 (100%) 1 Systolic pulmonary pressure (mmHg) 44.03 ± 10.58 45.86 ± 9.14 0.56 Etiology (%) Functional New York Heart Association Class III/IV Comorbidities (%) Echocardiography *Values are expressed as median and (25th-75th percentiles). COPD = Chronic Obstructive Pulmonary Disease, NTpro-BNP= N terminal-pro –Brain Natriuretic Peptide, STS = Society of Thoracic Surgeons